Assignee
RECEPTOS LLC
US·15 granted patents·6 pending applications·8 citations·filing 2017–2024
Top patents by PatentIndex Score
21 records- 0184US10882830B2Crystal form of ozanimod hydrochloride and processes for preparation thereforRECEPTOS LLC·Filed 2017·Granted Jan 5, 2021·2 cites·12 claims
- 0282US11040954B1CXCR3 receptor agonistsRECEPTOS LLC·Filed 2020·Granted Jun 22, 2021·2 cites·36 claims
- 0377US11117876B2Crystalline form of ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2018·Granted Sep 14, 2021·2 cites·9 claims
- 0477US11111223B2Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2017·Granted Sep 7, 2021·1 cites·36 claims
- 0574US11028060B2Crystalline forms of ozanimod and processes for preparation thereofRECEPTOS LLC·Filed 2017·Granted Jun 8, 2021·1 cites·17 claims
- 0671US11897848B2Crystalline forms of ozanimod and processes for preparation thereofRECEPTOS LLC·Filed 2021·Granted Feb 13, 2024·0 cites·20 claims
- 0769US2024261380A1Methods of treating atopic dermatitisRECEPTOS LLC·Filed 2024·Application pending·0 cites
- 0869US2024269249A1Methods of treating atopic dermatitisRECEPTOS LLC·Filed 2024·Application pending·0 cites
- 0966US11964005B2Methods of treating atopic dermatitisRECEPTOS LLC·Filed 2022·Granted Apr 23, 2024·0 cites·9 claims
- 1065US11680050B2Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2020·Granted Jun 20, 2023·0 cites·7 claims
- 1155US12428386B2Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 1255US12421199B2Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2021·Granted Sep 23, 2025·0 cites·8 claims
- 1355US12364686B2Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2021·Granted Jul 22, 2025·0 cites·10 claims
- 1448US11066395B2Dimethylaminoethanol salt of a GLP-1 receptor modulatorRECEPTOS LLC·Filed 2017·Granted Jul 20, 2021·0 cites·16 claims
- 1547US2022194971A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1647US2022194908A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1745US2022227722A1Sphingosine 1 phosphate receptor modulatorRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1845US2022144788A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1942US11278526B2Compounds and methods for treating lupusRECEPTOS LLC·Filed 2017·Granted Mar 22, 2022·0 cites·3 claims
- 2036US11530205B2GLP-1 receptor modulatorsRECEPTOS LLC·Filed 2018·Granted Dec 20, 2022·0 cites·18 claims
- 2132US11207301B2Sphingosine 1 phosphate receptor agonists for neuroprotectionRECEPTOS LLC·Filed 2018·Granted Dec 28, 2021·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →